The three largest vertically integrated PBMs control approximately 80% of the market and have a lot of clout. Escalating rebates for formulary access coupled with PBM measures to limit utilization continues to put pressure on gross and net sales.

By attending this virtual course, you'll learn about:

• Pharmaceutical ecosystem – PBMs, pharma companies, payers, providers, and patients
• Unique dynamics of PBM expansion, consolidation and vertical integration
• PBM revenue sources and impact of leveraging aggregated demand
• Impact of PBM formulary tiers, formulary exclusions, prior authorization and step edits
• Implications of escalating patient out-of-pocket costs on prescription abandonment
• Copay accumulators and maximizers
• Rebate walls
• ROI of PBM contracting scenarios
• PMB contract analytics & negotiating strategies
• Provisions and implications of the Inflation Reduction Act – Medicare price negotiation, inflation rebates and benefit redesign.
• Case study – negotiating rebates & market access with PBMs